Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3632)
All Articles published online
|
Jul 21, 2012 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi H, Lu L, Zhang NP, Zhang SC, Shen XZ. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment. World J Gastroenterol 2012; 18(27): 3617-3622 [PMID: 22826629 DOI: 10.3748/wjg.v18.i27.3617] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i27/3617.htm |
| Number | Citing Articles |
| 1 |
Li Wang, Zhi Qiang Zou, Cheng Xia Liu, Xiang Zhong Liu. Immunotherapeutic interventions in chronic hepatitis B virus infection: A review. Journal of Immunological Methods 2014; 407: 1 doi: 10.1016/j.jim.2014.04.004
|
| 2 |
Qin Pan, Rui-Nan Zhang, Yu-Qin Wang, Rui-Dan Zheng, Yu-Qiang Mi, Wen-Bin Liu, Feng Shen, Guang-Yu Chen, Jia-Fa Lu, Chan-Yan Zhu, Shu-Yi Zhang, Yi-Ming Chen, Wan-Lu Sun, Jian-Gao Fan. Linked <italic>PNPLA3</italic> polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B. World Journal of Gastroenterology 2015; 21(28): 8605-8614 doi: 10.3748/wjg.v21.i28.8605
|
| 3 |
G Caocci, F Murgia, L Podda, A Solinas, S Atzeni, G La Nasa. Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis. Leukemia 2014; 28(1): 225 doi: 10.1038/leu.2013.235
|
| 4 |
|
| 5 |
Forough Golsaz-Shirazi, Fazel Shokri. Hepatitis B Immunopathogenesis and Immunotherapy. Immunotherapy 2016; 8(4): 461 doi: 10.2217/imt.16.3
|
| 6 |
Lemonica Koumbi. Current and future antiviral drug therapies of hepatitis B chronic infection. World Journal of Hepatology 2015; 7(8): 1030-1040 doi: 10.4254/wjh.v7.i8.1030
|
| 7 |
Xia Liu, Zhijian Xu, Chuanwei Hou, Meng Wang, Xinhuan Chen, Qinghui Lin, Rui Song, Meng Lou, Lijun Zhu, Yunqing Qiu, Zhi Chen, Chunhao Yang, Weiliang Zhu, Jimin Shao. Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein. Biochemical Pharmacology 2016; 103: 118 doi: 10.1016/j.bcp.2016.01.003
|
| 8 |
Vivek K. Chaturvedi, Anshuman Singh, Sushil K. Dubey, Helal F. Hetta, James John, M.P. Singh. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microbial Pathogenesis 2019; 128: 184 doi: 10.1016/j.micpath.2019.01.004
|
| 9 |
S. A. Brezgin, A. P. Kostyusheva, V. N. Simirsky, E. V. Volchkova, D. S. Chistyakov, D. S. Kostyushev, V. P. Chulanov. Suppression of hepatitis b virus by a combined activity of CRISPR/Cas9 and HBx proteins. Russian Journal of Infection and Immunity 2019; 9(3-4): 476 doi: 10.15789/2220-7619-2019-3-4-476-484
|
| 10 |
Ming-Hua Liang, Shi-Shui Zhou, Jian-Guo Jiang. Construction, expression and characterization of a fusion protein HBscFv-IFNγ in Komagatella (Pichia) pastoris X33. Enzyme and Microbial Technology 2017; 102: 74 doi: 10.1016/j.enzmictec.2017.04.001
|